Nordic Digital Science & Innovation Day.

Sharing the latest trends, innovations, and best practices for digitizing R&D assets to accelerate modern science.

Abzu's keynote:

"Discovering RNA therapeutics with Abzu’s explainable AI."

Given by Lykke Pedersen, Abzu’s Chief Pharma Officer at the Nordic Digital Science & Innovation Day.

On the conference:

Hosted byThe BioInnovation Institute (BII) and Benchling.

The Nordic Digital Science & Innovation Day will bring together leading biotech organisations, consultancies, foundations and tech innovators in the region to share the latest trends, innovations and best practices for digitising R&D assets to accelerate modern science.

Discovering RNA therapeutics with Abzu’s explainable AI.

The Nordic Digital Science & Innovation Day abstract:

Two of the most promising advances in healthcare technology – RNA therapeutics and explainable AI – are fundamentally transforming what’s possible in the field of therapeutic development.

With symbolic regression, heterogenous data (such as sequences and multi-omics data) can effortlessly be integrated, and intricate nonlinear relationships can be revealed – even on wide datasets.

The core technology of Abzu, the QLattice®, is a symbolic regression engine that generates a veritably infinite number of mathematical models to explain fundamental interactions – and yet identifying and understanding interactions is easy with straightforward and simple models.

By using the QLattice, scientists gain a deeper understanding of biological and chemical mechanisms to create new drugs and modalities and increase their success rate, reducing the time required for drug discovery.

Share this event.

Abzu's impactful insights: On stage and in discussion.

Keynotes and panels that are shaping the future of RNA therapeutics.

OTS is a forum to foster academic and industry-based research and development of oligonucleotide therapeutics.
Investigating the next generation of genetic medicine through RNA-based therapies.
OTS is a forum to foster academic and industry-based research and development of oligonucleotide therapeutics.

Subscribe for
notifications from Abzu.

You can opt out at any time. We’re cookieless, and our privacy policy is actually easy to read.